Intact Mass Spectrometry for Protein Footprinting Dosimetry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for protein footprinting, such as synchrotron X-ray footprinting, face challenges in accurately determining the optimal dose of hydroxyl radicals for protein labeling, leading to inefficient experimental outcomes due to indirect dosimetry methods that provide feedback only after downstream analysis, resulting in prolonged optimization times and potential sample damage.

Innovation Solution

A direct assessment and control method using intact mass spectrometry to determine the average number of labels per protein molecule, allowing for immediate feedback on labeling extent and dose adjustment, thereby optimizing protein footprinting experiments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If indirect dosimetry methods (optical or fluorescence assays) are used to assess protein labeling, then the measurement process is simpler and faster, but the feedback is delayed until after downstream analysis and cannot reveal labeling problems until after the experiment is completed

Engineering Contradiction:
Improveoptimization timeVSAvoidlabeling extent assessment accuracy
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The patent implements direct feedback by measuring the mass-to-charge ratio of intact labeled proteins immediately after labeling, allowing real-time assessment of labeling extent and dose optimization without waiting for downstream analysis. This closed-loop feedback enables iterative dose adjustment during the labeling process itself.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces indirect optical/fluorescence measurement systems with direct mass spectrometry-based measurement. By using mass spectrometry to directly detect labeled proteins, the system eliminates the need for intermediate optical assays and provides more accurate, immediate feedback on labeling extent.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If higher doses of hydroxyl radicals are used to ensure adequate labeling, then labeling coverage improves, but sample damage and corruption increase due to over-labeling

Engineering Contradiction:
Improvelabeling coverageVSAvoidsample damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses mass spectrometry to provide real-time feedback on labeling extent, enabling precise control of hydroxyl radical dose. By monitoring the mass-to-charge ratio of intact proteins during labeling, the system can identify the optimal dose point where adequate labeling coverage is achieved without exceeding the threshold that causes sample damage or protein degradation.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent systematically varies the hydroxyl radical dose parameter and monitors the corresponding changes in mass spectrometry signals. By plotting labeling extent against dose and identifying the plateau region, the method determines the optimal dose that maximizes labeling coverage while minimizing harmful effects such as protein degradation.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If lower doses of hydroxyl radicals are used to avoid sample damage, then sample integrity is preserved, but labeling coverage becomes insufficient and data quality decreases

Engineering Contradiction:
Improvesample integrityVSAvoidlabeling coverage
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent performs dose-response experiments by systematically varying hydroxyl radical concentration and measuring the corresponding labeling extent via mass spectrometry. By analyzing the dose-response curve, the method identifies the minimum effective dose that achieves adequate labeling coverage while maintaining sample integrity, avoiding both under-labeling and over-labeling.

Inventive Principle:
Principle #35Parameter changes

4Loss of information

If bottom-up mass spectrometry analysis is performed after downstream processing, then detailed labeling site information can be obtained, but the time required for optimization increases and immediate feedback is lost

Engineering Contradiction:
Improvelabeling site detail informationVSAvoidexperiment optimization time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The patent performs preliminary intact mass spectrometry analysis immediately after labeling to assess labeling extent and optimize dose parameters. This preliminary action provides rapid feedback that guides subsequent experimental conditions, eliminating the need to wait for time-consuming downstream processing and bottom-up analysis before optimization can occur.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent segments the analysis into two distinct stages: (1) intact mass spectrometry for rapid labeling extent assessment and dose optimization, and (2) bottom-up mass spectrometry for detailed labeling site identification. By performing the preliminary intact analysis first, the method enables iterative optimization without delaying the final detailed characterization.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20240410897A1Intact mass spectrometry for direct protein footprinting dosimetry using covalent labeling
Publication Date: 2024.12.12 CASE WESTERN RESERVE UNIV
  • US20240410897A1 patent drawing
  • US20240410897A1 patent drawing
  • US20240410897A1 patent drawing

AI summary

The present disclosure provides a protein footprinting method based on mass spectrometry of an intact protein labeled with covalent labeling reagents, including hydroxyl radicals. The method involves intact MS screening of labeled samples and measurement of the extent of observed labeling (e.g., average oxidation events per protein) from the intact mass spectra. Advantageously, this direct, intact mass spectrometry-based approach can be used to determine a suitable dose range of the labeling agent relative to a subject protein in order to produce adequately labeled protein while avoiding damage to the subject protein caused by excessive use of the labeling agent.